pharma-company /Medicinal products /Active ingredients

Rx · PZN 13975625

QARZIBA 4,5 mg/ml 20mg concentrate for preparation of a solution for infusion vial

German trade nameQARZIBA 4,5 mg-ml 20mg Konzentrat zur Herstellung einer Infusionslösung Durchstechflasche

Active ingredientDinutuximab betaPharmaceutical formConcentrate for solution for infusion

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

N/A

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

QARZIBA 4,5 mg/ml 20mg concentrate for preparation of a solution for infusion vial contains the active ingredient Dinutuximab beta and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 13975625). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.

QARZIBA 4,5 mg/ml 20mg concentrate for preparation of a solution for infusion vial was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. No purchase price is available to us for this product.